Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Bezin

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Therapie|June 13, 2021
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspectsAntoine Pariente, Julien Bezin
Therapie|February 2, 2019
Pharmacoepidemiology of statinsJulien Bezin, Nicholas Moore
American Journal of Hypertension|May 18, 2025
Effect of the COVID-19 epidemic on the association between antihypertensive drug interruption and the risk of major cardiovascular event in FranceClément Mathieu, Julien Bezin, Antoine Pariente
Frontiers in Pharmacology|May 31, 2023
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysisClément Mathieu, Julien Bezin, Antoine Pariente
La Revue Du Praticien|December 5, 2018
Pharmacoepidemiology: how to assess medicines in real-life setting?Julien Bezin, Pauline Bosco-Levy, Antoine Pariente
Therapie|November 17, 2019
Polypharmacy: A general review of definitions, descriptions and determinantsJordan Guillot, Sandy Maumus-Robert, Julien Bezin
Therapie|June 6, 2017
False-positive results in pharmacoepidemiology and pharmacovigilanceJulien Bezin, Pauline Bosco-Levy, Antoine Pariente
Therapie|December 14, 2022
Systematic review on sex differences for drug use after strokeJulia Perrier, Mathilde Renard, Antoine Pariente, et al.
Drug Safety|April 12, 2023
Drug-Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based StudyLouis Létinier, Julien Bezin, Ana Jarne, et al.
Diabetes Care|May 15, 2023
Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390Julien Bezin, Clément Mathieu, Jean-Luc Faillie, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Therapie|June 13, 2021
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspectsAntoine Pariente, Julien Bezin
Therapie|February 2, 2019
Pharmacoepidemiology of statinsJulien Bezin, Nicholas Moore
American Journal of Hypertension|May 18, 2025
Effect of the COVID-19 epidemic on the association between antihypertensive drug interruption and the risk of major cardiovascular event in FranceClément Mathieu, Julien Bezin, Antoine Pariente
Frontiers in Pharmacology|May 31, 2023
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysisClément Mathieu, Julien Bezin, Antoine Pariente
La Revue Du Praticien|December 5, 2018
Pharmacoepidemiology: how to assess medicines in real-life setting?Julien Bezin, Pauline Bosco-Levy, Antoine Pariente
Therapie|November 17, 2019
Polypharmacy: A general review of definitions, descriptions and determinantsJordan Guillot, Sandy Maumus-Robert, Julien Bezin
Therapie|June 6, 2017
False-positive results in pharmacoepidemiology and pharmacovigilanceJulien Bezin, Pauline Bosco-Levy, Antoine Pariente
Therapie|December 14, 2022
Systematic review on sex differences for drug use after strokeJulia Perrier, Mathilde Renard, Antoine Pariente, et al.
Drug Safety|April 12, 2023
Drug-Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based StudyLouis Létinier, Julien Bezin, Ana Jarne, et al.
Diabetes Care|May 15, 2023
Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390Julien Bezin, Clément Mathieu, Jean-Luc Faillie, et al.
Pageof 8